ASSESSMENT OF THE QUALITY OF LIFE AND PSYCHO-EMOTIONAL STATE OF PATIENTS WITH SHERESHEVSKY-TURNER SYNDROME
Keywords:
STS, short stature, quality of life, health componentAbstract
The purpose of the study. To study the indicators of quality of life in patients with Shereshevsky-Turner syndrome.
Material and methods. The study included 69 females aged 16 to 23 years, the average age was 20.3±1.9 years. The main group included 43 patients with STS, mean age was 20.1±1.3 years. The control group included 26 healthy individuals aged 20.5±2.6 years. The groups were comparable in terms of age (p=0.40) and BMI (p=0.29). To assess the quality of life of patients, a short version of the MOS 36-Item Short-Form Health Survey (MOS SF-36) was used. The 36 items on the questionnaire are grouped into eight scales: physical functioning (PF), role functioning (RP), bodily pain (BP), general health (GH), vital activity (VT), social functioning (SF), role emotional functioning (RE) and mental health (MH).
Results and discussion. The analysis of the parameters of the physical component of health showed that the integral indicator of the physical component of health (PCH) varied from 53.3 to 58.4 points with Me 55.8 points in STS. These indicators are significantly lower than the control values (Me 76.6; IQR 71.4-80.5). Adolescent girls with STS are at high risk of developing problems associated with lower social activity, poor social coping skills, and increased immaturity, hyperactivity, and impulsivity compared to their peers. In addition, patients with STS often have difficulty maintaining relationships with their peers.
Conclusions. The main clinical signs of STS in the studied cohort were short stature, primary amenorrhea, sexual infantilism, a significant proportion of patients have a wide chest, X-shaped curvature of the legs, skin folds on the neck, more than a third were diagnosed with arterial hypertension. According to the results of the survey, there is a significant decrease in the parameters of the physical (by 26.5%) and psychological (29.3%) components of health and quality of life.
References
Amedro P., Tahhan N., Bertet H. et al. Health-related quality of life among children with Turner syndrome: controlled cross-sectional study. J Pediatr Endocrinol Metab. 2017; 30(8): 863–868. doi: 10.1515/jpem-2017-0026
Backeljauw P., Cappa M., Kiess W. et al. Impact of short stature on quality of life: A systematic literature review. Growth Horm IGF Res. 2021; 57-58: 101392. doi: 10.1016/j.ghir.2021.101392.
Davenport M. Approach to the patient with Turner syndrome. J Clin Endocrinol Metab. 2010; 95(4):1 487-1495. doi: 10.1210/jc.2009-0926.
Dołęga Z., Turek A., Irzyniec T., Jeż W. Płeć psychologiczna, obraz ciała i poczucie samotności kobiet po otrzymaniu rozpoznania zespołu Turnera. Czasopismo Psychologiczne. 2012; 18: 143–153.
Gravholt C., Viuff M., Brun S. et al. Turner syndrome: Mechanisms and management. Nat. Rev. Endocrinol. 2019; 15: 601–614. doi: 10.1038/s41574-019-0224-4.
Huang A., Olson S., Maslen C. A Review of Recent Developments in Turner Syndrome Research. J Cardiovasc Dev Dis. 2021; 8(11): 138. doi: 10.3390/jcdd8110138.
Jeż W., Tobiasz-Adamczyk B., Brzyski P. et al. Social and medical determinants of quality of life and life satisfaction in women with Turner syndrome. Adv Clin Exp Med. 2018; 27(2): 229-236. doi: 10.17219/acem/66986.
Kesler S. Turner syndrome. Child Adolesc Psychiatr Clin N Am. 2007; 16(3): 709-722. doi: 10.1016/j.chc.2007.02.004.
Lin A., Prakash S., Andersen N. et al. Recognition and management of adults with Turner syndrome: From the transition of adolescence through the senior years. Am. J. Med. Genet. Part A. 2019; 179:1 987–2033. doi: 10.1002/ajmg.a.61310.
McCauley E., Feuillan P., Kushner H., Ross J. Psychosocial development in adolescents with Turner syndrome. J Dev Behav Pediatr. 2001; 22(6): 360-365. doi: 10.1097/00004703- 200112000-00003.
Morgan T. Turner syndrome: diagnosis and management. Am Fam Physician. 2007; 76(3): 405- 10.
Mortensen K., Andersen N., Gravholt C. Cardiovascular phenotype in Turner syndrome-- integrating cardiology, genetics, and endocrinology. Endocr. Rev. 2012; 33: 677–714. doi: 10.1210/er.2011-1059.
Naess E., Bahr D., Gravholt C. Health status in women with Turner syndrome: a questionnaire study on health status, education, work participation and aspects of sexual functioning. Clin Endocrinol (Oxf). 2010; 72(5): 678–684. doi: 10.1111/j.1365-2265.2009.03715.x
Silberbach M., Roos-Hesselink J., Andersen N. et al. Cardiovascular Health in Turner Syndrome: A Scientific Statement from the American Heart Association. Circ. Genom. Precis. Med. 2018; 11: e000048. doi: 10.1161/HCG.0000000000000048.
Stochholm K., Juul S., Juel K. et al. Prevalence, Incidence, Diagnostic Delay, and Mortality in Turner Syndrome. J. Clin. Endocrinol. Metab. 2006; 91: 3897–3902. doi: 10.1210/jc.2006- 0558.
Sutton E., McInerney-Leo A., Bondy C. et al. Turner syndrome: four challenges across the lifespan. Am J Med Genet A. 2005;1 39A(2): 57-66. doi: 10.1002/ajmg.a.30911.
Thompson T., Zieba B., Howell S. et al. A mixed methods study of physical activity and quality of life in adolescents with Turner syndrome. Am J Med Genet A. 2020; 182(2): 386-396. doi: 10.1002/ajmg.a.61439.
